Cosomil
Tokyo
About Cosomil
Cosomil develops early diagnostic drugs for diseases and provides research and development support to healthcare companies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2026)
- Website: cosomil.com
- Phone: +81 03-6823-2260
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cosomil-2187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.